Drugs / Diphtheria and tetanus vaccine (adsorbed, reduced antigen content, Germany)
Diphtheria and tetanus vaccine (adsorbed, reduced antigen content, Germany)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01529645 Background | Mar → Jul 2012 | diphtheria, pertussis, tetanus | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Diphtheria and tetanus vaccine (adsorbed, reduced antigen content, Germany) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01529645 ↗ |
| Modality | Vaccine | “Diphtheria and tetanus vaccine (adsorbed, reduced antigen content, Germany)” NCT01529645 ↗ |